Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer's disease

Abstract

Background: Inflammation plays an integral role in Alzheimer's disease (AD), and chemokine CX3CL1 (C‐X3‐C motif ligand 1, aka Fractalkine), emerging as a key molecule linking inflammatory and neuroprotective mechanisms within the central nervous system, play a special role in the development of AD and ageing.

The paper